Author Affiliations: HIV Molecular Research Group, School of Medicine and Medical Science, University College Dublin, and Department of Infectious Diseases, Mater Misericordiae University Hospital, Dublin, Ireland.
For people infected with the human immunodeficiency virus (HIV) with access to antiretroviral therapy (ART), the benefits, particularly for those with low CD4+ T-cell counts, have been clearly established.1 Management strategies have shifted firmly toward earlier HIV diagnosis to reduce HIV-related morbidity alongside increased ART access to maximize its benefits with a view to mitigating the potential detrimental effects of HIV infection on overall lifelong survival.
Mallon PWG. Getting to the Heart of HIV and Myocardial InfarctionComment on “HIV Infection and the Risk of Acute Myocardial Infarction”. JAMA Intern Med. 2013;173(8):622–623. doi:10.1001/jamainternmed.2013.264